US Stock MarketDetailed Quotes

MORF Morphic

Watchlist
  • 28.500
  • +0.510+1.82%
Close Apr 22 16:00 ET
1.43BMarket Cap-7938P/E (TTM)

About Morphic Company

Morphic Holding, Inc., operates as a biopharmaceutical company, which researches and develops oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

Company Profile

SymbolMORF
Company NameMorphic
Listing DateJun 27, 2019
Issue Price15.00
Founded2014
CEODr. Praveen P. Tipirneni, M.D.
MarketNASDAQ
Employees121
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address35 Gatehouse Drive A2
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-996-0955

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Praveen P. Tipirneni, M.D.
  • Chief Executive Officer and Director
  • 10.52M
  • Robert E. Farrell, C.P.A.,Jr
  • Assistant Treasurer, Senior Vice President of Finance and Chief Accounting Officer
  • --
  • Dr. Marc Schegerin, M.D.
  • Chief Financial Officer and Chief Operating Officer
  • 4.35M
  • Gustav A. Christensen
  • Chairman of the Board
  • 390.64K
  • Dr. Bruce N. Rogers, PhD
  • President
  • 5.26M
  • Dr. Timothy A. Springer, PhD
  • Independent Director
  • 346.64K
  • Susannah Gray, M.B.A.
  • Independent Director
  • 354.14K
  • Joseph P. Slattery, C.P.A.
  • Independent Director
  • 366.64K
  • Amir H. Nashat, PhD
  • Independent Director
  • 350.64K
  • Professor Dr. Norbert W. Bischofberger, PhD
  • Independent Director
  • 351.64K
  • Dr. Nisha Nanda, PhD
  • Independent Director
  • 346.64K
  • Dr. Martin William Edwards, M.D.
  • Independent Director
  • 353.03K
  • William D. DeVaul, Esq.
  • General Counsel and Secretary
  • 790.25K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg